1 | CYP2D6, CYP2D6DM
|
| CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
|
| Halling J, Weihe P, Brosen K.
|
| Ther Drug Monit 30(3):271-5. 2008
|
2 | CYP2D6, CYP2D6DM, CYP2D7P1
|
| A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.
|
| Pai HV, Kommaddi RP, Chinta SJ, Mori T, Boyd MR, Ravindranath V.
|
| J Biol Chem 279(26):27383-9. Epub 2004 Mar 29. 2004
|
3 | CYP2D6, CYP2D6DM
|
| Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
|
| Saxena R, Shaw GL, Relling MV, Frame JN, Moir DT, Evans WE, Caporaso N, Weiffenbach B.
|
| Hum Mol Genet 3 : 923-926. 1994
|
4 | CYP2D6, CYP2D6DM
|
| DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6) : evidence for two major allozymes in extensive metabolisers.
|
| Panserat S, et al.
|
| Hum Genet 94 : 401-406. 1994
|
5 | CYP2D6, CYP2D6DM
|
| Debrisoquine/sparteine hydroxylation genotype and phenotype : analysis of common mutations and alleles of CYP2D6 in a european population.
|
| Broly F, et al.
|
| DNA Cell Biol 10 : 545-558. 1991
|
6 | CYP2D6, CYP2D6DM
|
| Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.
|
| Heim M, et al.
|
| Lancet 336 : 529-532. 1990
|
7 | CYP2D6, CYP2D6DM
|
| Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
|
| Kagimoto M, et al.
|
| J Biol Chem 265 : 17209-17214. 1990
|
8 | CYP2D6, CYP2D6DM
|
| The human CYP2D locus associated with a common genetic defect in drug oxidation: A G1934-A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.
|
| Hanioka N, et al.
|
| Am J Hum Genet 47 : 994-1001. 1990
|
9 | CYP2D6, CYP2D6DM
|
| Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.
|
| Gonzalez FJ, et al.
|
| Nature 331 : 442-446. 1988
|